Amir Lerman, Eric Eeckhout. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Coronary Artery Disease/chemically inducedCoronary Restenosis/drug therapyDrug ImplantsHumansImmunosuppressive Agents/administration & dosageProspective StudiesRisk FactorsSirolimus/administration & dosageStents/adverse effects
Substances: See more » Drug ImplantsImmunosuppressive AgentsSirolimus
Year: 2005 PMID: 16278231 DOI: 10.1093/eurheartj/ehi641
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983